ETYA is a nonspecific inhibitor of cyclooxygenases and lipoxygenases.1 ETYA inhibits human platelet 12-LO and COX-1 with IC50 values of 4 µM and 8 µM, respectively.1 ETYA is a PPAR ligand which activates PPARα and PPARγ chimeras at concentrations of 10 µM.2
1
Hammarström, S. Selective inhibition of platelet n-8 lipoxygenase by 5,8,11-eicosatriynoic acid. Biochim Biophys Acta 487 517-519 (1977).
2
Kliewer, S.A., Lenhard, J.M., Willson, T.M., et al. A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation. Cell 83 813-819 (1995).
Hammarström, S. Selective inhibition of platelet n-8 lipoxygenase by 5,8,11-eicosatriynoic acid. Biochim Biophys Acta 487 517-519 (1977).
Tobias, L.D., and Hamilton, J.G. The effect of 5,8,11,14-eicosatetraynoic acid on lipid metabolism. Lipids 14 181-193 (1979).
Downing, D.T., Barve, J.A., Gunstone, F.D., et al. Structural requirements of acetylenic fatty acids for inhibition of soybean lipoxygenase and prostaglandin synthase. Biochim Biophys Acta 280 343-347 (1972).
Kühn, H., Holzhütter, H., Schewe, T., et al. The mechanism of inactivation of lipoxygenases by acetylenic fatty acids. Eur J Biochem 139 577-583 (1984).
Taylor, A.S., Morrison, A.R., and Russell, J.H. Incorporation of 5,8,11,14-eicosatetraynoic acid (ETYA) into cell lipids: Competition with arachidonic acid for esterification. Prostaglandins 29 449-458 (1985).
Kliewer, S.A., Lenhard, J.M., Willson, T.M., et al. A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation. Cell 83 813-819 (1995).
Show all 6
Hide all but first 3